A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

May 20, 2020

Study Completion Date

August 7, 2020

Conditions
Osteoarthritis, Knee
Interventions
DRUG

UBX0101

Investigational drug intra-articular injection

OTHER

Placebo

Placebo intra-articular injection

Trial Locations (20)

10530

Drug Trials America, Hartsdale

14609

Rochester Clinical Research, Rochester

16635

Altoona Center for Clinical Research, Duncansville

29406

Coastal Carolina Research Center, North Charleston

32159

Charter Research, Lady Lake

Premier Medical Associates, The Villages

33143

Well-Pharma Medical Research, Miami

33351

Precision Clinical Research, Sunrise

35205

Central Research Associates, Birmingham

36608

Coastal Clinical Research, LLC., Mobile

40509

Alliance for Multispecialty Research-Lexington, Lexington

60607

Chicago Clinical Research Institute, Chicago

64114

The Alliance for Multispecialty Research, Kansas City

67207

The Alliance for Multispecialty Research, Wichita

85283

Fiel Family and Sports Medicine, Tempe

85712

Tucson Orthopaedic Institute, Tucson

87102

Albuquerque Clinical Trials, Albuquerque

91942

Biosolutions Clinical Research Center, La Mesa

94598

Diablo Clinical Research, Walnut Creek

08009

Hassman Research Institute, Berlin

All Listed Sponsors
lead

Unity Biotechnology, Inc.

INDUSTRY

NCT04129944 - A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter